Glazer Capital LLC’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Glazer Capital LLC’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,400	Closed	-$110K	–	98
2015 Q1	$110K	Buy	+2,400	New	+$71.8K	0.02%	58

Glazer Capital LLC's HPTX Position: Q2 2015 in Review

Glazer Capital LLC sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 2,400 shares — an estimated $110K sold.

Glazer Capital LLC first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $110K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Glazer Capital LLC reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Glazer Capital LLC sold 2,400 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $110K.
Glazer Capital LLC first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Glazer Capital LLC's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $110K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Glazer Capital LLC's 13F filing for Q2 2015, filed 14 Aug 2015.